chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Fatigue, HIV test, Oedema peripheral
Clinical narrative: Liquid has accumulated at the bicep area, it's just sitting there.; right arm is all swollen from the bicep to the crrok of the arm; right arm is all red; Was really tired; Had no energy; No appetite; That night arm started itching/It was still itching; This spontaneous case was reported by a patient and describes the occurrence of EDEMA PERIPHERAL (Liquid has accumulated at the bicep area, it's just sitting there.), ASTHENIA (Had no energy), DECREASED APPETITE (No appetite), VACCINATION SITE PRURITUS (That night arm started itching/It was still itching) and FATIGUE (Was really tired) in an 83-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 055F22B) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart attack. Concurrent medical conditions included Prostate cancer and HIV disease (HIV positive, was tested in 1985) since 1985.    On 15-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 15-Oct-2022, the patient experienced VACCINATION SITE PRURITUS (That night arm started itching/It was still itching). On 16-Oct-2022, the patient experienced ASTHENIA (Had no energy), DECREASED APPETITE (No appetite) and FATIGUE (Was really tired). On 17-Oct-2022, the patient experienced EDEMA PERIPHERAL (Liquid has accumulated at the bicep area, it's just sitting there.), VACCINATION SITE SWELLING (right arm is all swollen from the bicep to the crook of the arm) and VACCINATION SITE ERYTHEMA (right arm is all red). The patient was treated with HYDROCORTISONE for Itching, at a dose of 1 % percent w aloe. At the time of the report, EDEMA PERIPHERAL (Liquid has accumulated at the bicep area, it's just sitting there.) and VACCINATION SITE PRURITUS (That night arm started itching/It was still itching) had not resolved and ASTHENIA (Had no energy), DECREASED APPETITE (No appetite), FATIGUE (Was really tired), VACCINATION SITE SWELLING (right arm is all swollen from the bicep to the crook of the arm) and VACCINATION SITE ERYTHEMA (right arm is all red) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 1985, HIV test: (Positive) Positive. No concomitant medications were reported. Patient's previous vaccination includes 1st Dose on 12-Jan-2021 with lot no. 039K20A, 2nd Dose on 09-Feb-2021 with lot no. 012M20A, 1st Booster dose on 28-Oct-2021 with lot no. 071F21A and 2nd Booster dose on 08-Apr-2022 with lot no. 033K2-2A. Treatment medication was Hydrocortisone cream 1% w Aloe.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Liquid has accumulated at the bicep area, it's just sitting there.; right arm is all swollen from the bicep to the crrok of the arm; right arm is all red; Was really tired; Had no energy; No appetite; That night arm started itching/It was still itching; This spontaneous case was reported by a patient and describes the occurrence of EDEMA PERIPHERAL (Liquid has accumulated at the bicep area, it's just sitting there.), ASTHENIA (Had no energy), DECREASED APPETITE (No appetite), VACCINATION SITE PRURITUS (That night arm started itching/It was still itching) and FATIGUE (Was really tired) in an 83-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 055F22B) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart attack. Concurrent medical conditions included Prostate cancer and HIV disease (HIV positive, was tested in 1985) since 1985.    On 15-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 15-Oct-2022, the patient experienced VACCINATION SITE PRURITUS (That night arm started itching/It was still itching). On 16-Oct-2022, the patient experienced ASTHENIA (Had no energy), DECREASED APPETITE (No appetite) and FATIGUE (Was really tired). On 17-Oct-2022, the patient experienced EDEMA PERIPHERAL (Liquid has accumulated at the bicep area, it's just sitting there.), VACCINATION SITE SWELLING (right arm is all swollen from the bicep to the crook of the arm) and VACCINATION SITE ERYTHEMA (right arm is all red). The patient was treated with HYDROCORTISONE for Itching, at a dose of 1 % percent w aloe. At the time of the report, EDEMA PERIPHERAL (Liquid has accumulated at the bicep area, it's just sitting there.) and VACCINATION SITE PRURITUS (That night arm started itching/It was still itching) had not resolved and ASTHENIA (Had no energy), DECREASED APPETITE (No appetite), FATIGUE (Was really tired), VACCINATION SITE SWELLING (right arm is all swollen from the bicep to the crook of the arm) and VACCINATION SITE ERYTHEMA (right arm is all red) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 1985, HIV test: (Positive) Positive. No concomitant medications were reported. Patient's previous vaccination includes 1st Dose on 12-Jan-2021 with lot no. 039K20A, 2nd Dose on 09-Feb-2021 with lot no. 012M20A, 1st Booster dose on 28-Oct-2021 with lot no. 071F21A and 2nd Booster dose on 08-Apr-2022 with lot no. 033K2-2A. Treatment medication was Hydrocortisone cream 1% w Aloe.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Feeling abnormal, Myalgia, Nausea, Syncope
Clinical narrative: feeling a little under the weather; fatigue; nausea; little bit of body ache; faint 14 to 16 hours later after dose 2; This spontaneous case was reported by a patient and describes the occurrence of SYNCOPE (faint 14 to 16 hours later after dose 2), FEELING ABNORMAL (feeling a little under the weather), FATIGUE (fatigue), NAUSEA (nausea) and MYALGIA (little bit of body ache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036L20A and 011J20A) for COVID-19 prophylaxis.     Concomitant products included ALENDRONATE SODIUM (ALENDRONATE) for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced SYNCOPE (faint 14 to 16 hours later after dose 2). On an unknown date, the patient experienced FEELING ABNORMAL (feeling a little under the weather), FATIGUE (fatigue), NAUSEA (nausea) and MYALGIA (little bit of body ache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of once or twice. At the time of the report, SYNCOPE (faint 14 to 16 hours later after dose 2), FEELING ABNORMAL (feeling a little under the weather), FATIGUE (fatigue), NAUSEA (nausea) and MYALGIA (little bit of body ache) outcome was unknown.            This case was linked to MOD-2022-659978, MOD-2022-659976, MOD-2022-659972 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Malaise, Myalgia, Nausea, Syncope
Clinical narrative: feeling a little under the weather; fatigue; nausea; little bit of body ache; faint 14 to 16 hours later after dose 2; This spontaneous case was reported by a patient and describes the occurrence of SYNCOPE (faint 14 to 16 hours later after dose 2), FEELING ABNORMAL (feeling a little under the weather), FATIGUE (fatigue), NAUSEA (nausea) and MYALGIA (little bit of body ache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036L20A and 011J20A) for COVID-19 prophylaxis.     Concomitant products included ALENDRONATE SODIUM (ALENDRONATE) for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced SYNCOPE (faint 14 to 16 hours later after dose 2). On an unknown date, the patient experienced FEELING ABNORMAL (feeling a little under the weather), FATIGUE (fatigue), NAUSEA (nausea) and MYALGIA (little bit of body ache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of once or twice. At the time of the report, SYNCOPE (faint 14 to 16 hours later after dose 2), FEELING ABNORMAL (feeling a little under the weather), FATIGUE (fatigue), NAUSEA (nausea) and MYALGIA (little bit of body ache) outcome was unknown.            This case was linked to MOD-2022-659978, MOD-2022-659976, MOD-2022-659972 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: feeling a little under the weather; fatigue; nausea; little bit of body ache; faint 14 to 16 hours later after dose 2; This spontaneous case was reported by a patient and describes the occurrence of SYNCOPE (faint 14 to 16 hours later after dose 2), FEELING ABNORMAL (feeling a little under the weather), FATIGUE (fatigue), NAUSEA (nausea) and MYALGIA (little bit of body ache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036L20A and 011J20A) for COVID-19 prophylaxis.     Concomitant products included ALENDRONATE SODIUM (ALENDRONATE) for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced SYNCOPE (faint 14 to 16 hours later after dose 2). On an unknown date, the patient experienced FEELING ABNORMAL (feeling a little under the weather), FATIGUE (fatigue), NAUSEA (nausea) and MYALGIA (little bit of body ache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of once or twice. At the time of the report, SYNCOPE (faint 14 to 16 hours later after dose 2), FEELING ABNORMAL (feeling a little under the weather), FATIGUE (fatigue), NAUSEA (nausea) and MYALGIA (little bit of body ache) outcome was unknown.            This case was linked to MOD-2022-659978, MOD-2022-659976, MOD-2022-659972 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Feeling abnormal, Myalgia, SARS-CoV-2 test
Clinical narrative: feeling a little under the weather; body ache after each vaccine but not really bad; patient  caught Covid19; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (feeling a little under the weather), COVID-19 (patient  caught Covid19) and MYALGIA (body ache after each vaccine but not really bad) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045J2VA, 011J20A and 036L20A) for COVID-19 prophylaxis.     No Medical History information was reported.  Concomitant products included ALENDRONATE SODIUM (ALENDRONATE) for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Sep-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (patient  caught Covid19). On an unknown date, the patient experienced FEELING ABNORMAL (feeling a little under the weather) and MYALGIA (body ache after each vaccine but not really bad). The patient was treated with PARACETAMOL (TYLENOL) at a dose of once or twice after having the vaccine. At the time of the report, FEELING ABNORMAL (feeling a little under the weather), COVID-19 (patient  caught Covid19) and MYALGIA (body ache after each vaccine but not really bad) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Aug-2022, SARS-CoV-2 test: (Negative) Negative.         The patient was tested negative for Covid on 31-Aug-2022 before the colonoscopy. Patient had colonoscopy test ,its result was unknown.   This case was linked to MOD-2022-659978, MOD-2022-659972, MOD-2022-659974 (Patient Link).
Age: 9.0
Sex: U
Vaccine: COVID19
Symptoms: Accidental overdose, No adverse event
Clinical narrative: Patient received 0.50mL instead of 0.25 mL from Moderna Covid 19 Bivalent; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (Patient received 0.50mL instead of 0.25 mL from Moderna Covid 19 Bivalent) and NO ADVERSE EVENT (No adverse event) in a 9-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (Patient received 0.50mL instead of 0.25 mL from Moderna Covid 19 Bivalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL OVERDOSE (Patient received 0.50mL instead of 0.25 mL from Moderna Covid 19 Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL OVERDOSE (Patient received 0.50mL instead of 0.25 mL from Moderna Covid 19 Bivalent).    No concomitant medication was reported.     HCP  stated that one of his intense might have accidentally administered 0.50mL instead of 0.25 mL Moderna Covid 19 Bivalent.  No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-659986 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-659986:Patient 1 case
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event, Product leakage
Clinical narrative: No adverse event; vaccine leaked out as if there was something weak with the needle; vaccine leaked when being administered; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT LEAKAGE (vaccine leaked out as if there was something weak with the needle), INCORRECT DOSE ADMINISTERED (vaccine leaked when being administered) and NO ADVERSE EVENT (No adverse event) in a 65-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Pfizer (Dose 2) and Pfizer (Dose 1). Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer.    On 17-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 17-Oct-2022, the patient experienced PRODUCT LEAKAGE (vaccine leaked out as if there was something weak with the needle) and INCORRECT DOSE ADMINISTERED (vaccine leaked when being administered). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT LEAKAGE (vaccine leaked out as if there was something weak with the needle), INCORRECT DOSE ADMINISTERED (vaccine leaked when being administered) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT LEAKAGE (vaccine leaked out as if there was something weak with the needle) and INCORRECT DOSE ADMINISTERED (vaccine leaked when being administered).    No concomitant medications were reported.  Patient had 1 Moderna booster prior to this dose.   It was reported that after injecting the bivalent booster dose part of the vaccine leaked out as if there was something weak with the needle or there was a "clicking mechanism" that was heard.   No treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event; Got the Bivalent vaccine before they got the primary series; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Got the Bivalent vaccine before they got the primary series) and NO ADVERSE EVENT (No adverse event) in an adult male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In October 2022, the patient experienced WRONG PRODUCT ADMINISTERED (Got the Bivalent vaccine before they got the primary series). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Got the Bivalent vaccine before they got the primary series) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Got the Bivalent vaccine before they got the primary series). The patient was an adult man in his early 30s. Concomitant product use was not provided by the reporter. It was reported that the patient got the Bivalent vaccine before they got the primary series sometime last week but they did not know the specific date.  Treatment information was not provided.   Reporter did not allow further contact
Age: 69.0
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: Erythema, Itching scar, Pustule, Scratch
Clinical narrative: itchiness on the BCG/TB vaccination scar; Small pustules; Scratching it made it worse; Redness; This spontaneous case was reported by a patient and describes the occurrence of ITCHING SCAR (itchiness on the BCG/TB vaccination scar), PUSTULE (Small pustules), SCRATCH (Scratching it made it worse) and ERYTHEMA (Redness) in a 69-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7144B) for COVID-19 vaccination.    Co-suspect product included non-company product INFLUENZA VACCINE for an unknown indication.    Concomitant products included LEVOTHYROXINE, FLUVASTATIN, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HCTZ), ATENOLOL, PAROXETINE, VITAMIN D NOS and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 15-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient started INFLUENZA VACCINE (unknown route) at an unspecified dose. In October 2022, the patient experienced ITCHING SCAR (itchiness on the BCG/TB vaccination scar), PUSTULE (Small pustules), SCRATCH (Scratching it made it worse) and ERYTHEMA (Redness). At the time of the report, ITCHING SCAR (itchiness on the BCG/TB vaccination scar), PUSTULE (Small pustules), SCRATCH (Scratching it made it worse) and ERYTHEMA (Redness) had not resolved.            The patient received moderna dose 1 on apr-2021, dose 2 was received 6 weeks after dose 1, first booster dose and second booster dose on apr-2022. The patient had never tested COVID positive or diagnosis. Patient had no allergies. The adverse event did not cause patient to seek medical care. The patient never had  experienced a similar event in the past. It was reported that symptoms were improved. Treatment medication included topical cream.   This case was linked to MOD-2022-660219, MOD-2022-660211 (Patient Link).
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No adverse event; 2nd dose Moderna 6 weeks after the 1st dose; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose Moderna 6 weeks after the 1st dose) and NO ADVERSE EVENT (No adverse event) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Patient did not have any allergies. Patient had not been tested positive for COVID-19. He did not have any Acute and Chronic illnesses at the time of vaccination.  Concomitant products included LEVOTHYROXINE, FLUVASTATIN, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HCTZ), ATENOLOL, PAROXETINE, VITAMIN D [VITAMIN D NOS] and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose Moderna 6 weeks after the 1st dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose Moderna 6 weeks after the 1st dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            Patient received the 2nd dose of Moderna 6 weeks after the 1st dose. No treatment medications were reported.   This case was linked to MOD-2022-660211, MOD-2022-660180 (Patient Link).
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pruritus
Clinical narrative: No adverse event; 2nd dose Moderna 6 weeks after the 1st dose; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose Moderna 6 weeks after the 1st dose) and NO ADVERSE EVENT (No adverse event) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Patient did not have any allergies. Patient had not been tested positive for COVID-19. He did not have any Acute and Chronic illnesses at the time of vaccination.  Concomitant products included LEVOTHYROXINE, FLUVASTATIN, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HCTZ), ATENOLOL, PAROXETINE, VITAMIN D [VITAMIN D NOS] and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose Moderna 6 weeks after the 1st dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose Moderna 6 weeks after the 1st dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            Patient received the 2nd dose of Moderna 6 weeks after the 1st dose. No treatment medications were reported.   This case was linked to MOD-2022-660211, MOD-2022-660180 (Patient Link).
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Itchiness; This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (Itchiness) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Patient had no allergies. Patient had no history relating to mentioned AE and both acute and chronic illnesses at the time of vaccination.  Concomitant products included LEVOTHYROXINE, FLUVASTATIN, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HCTZ), ATENOLOL, PAROXETINE, VITAMIN D [VITAMIN D NOS] and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2022, the patient experienced PRURITUS (Itchiness). At the time of the report, PRURITUS (Itchiness) was resolving.            The patient had never tested COVID positive or diagnosis.  Treatment medication included topical cream.   This case was linked to MOD-2022-660219, MOD-2022-660180 (Patient Link).
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pruritus
Clinical narrative: Itchiness; This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (Itchiness) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Patient had no allergies. Patient had no history relating to mentioned AE and both acute and chronic illnesses at the time of vaccination.  Concomitant products included LEVOTHYROXINE, FLUVASTATIN, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HCTZ), ATENOLOL, PAROXETINE, VITAMIN D [VITAMIN D NOS] and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2022, the patient experienced PRURITUS (Itchiness). At the time of the report, PRURITUS (Itchiness) was resolving.            The patient had never tested COVID positive or diagnosis.  Treatment medication included topical cream.   This case was linked to MOD-2022-660219, MOD-2022-660180 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bedridden, Blood glucose, Blood glucose abnormal, Decreased appetite, Feeling abnormal
Clinical narrative: Could not get out of bed after the first booster shot; Nausea after the first booster shot, Did not know what day it was after the first booster shot; Sugar was out of range after the first booster shot; Had 5 blankets on her after the first booster shot; Could not eat after the first booster shot; This spontaneous case was reported by a patient and describes the occurrence of BEDRIDDEN (Could not get out of bed after the first booster shot), NAUSEA (Nausea after the first booster shot, Did not know what day it was after the first booster shot), BLOOD GLUCOSE ABNORMAL (Sugar was out of range after the first booster shot), FEELING ABNORMAL (Had  5 blankets on her after the first booster shot) and DECREASED APPETITE (Could not eat after the first booster shot) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031C21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, the patient experienced BEDRIDDEN (Could not get out of bed after the first booster shot), NAUSEA (Nausea after the first booster shot, Did not know what day it was after the first booster shot), BLOOD GLUCOSE ABNORMAL (Sugar was out of range after the first booster shot), FEELING ABNORMAL (Had  5 blankets on her after the first booster shot) and DECREASED APPETITE (Could not eat after the first booster shot). On 07-Nov-2021, BEDRIDDEN (Could not get out of bed after the first booster shot), NAUSEA (Nausea after the first booster shot, Did not know what day it was after the first booster shot), BLOOD GLUCOSE ABNORMAL (Sugar was out of range after the first booster shot), FEELING ABNORMAL (Had  5 blankets on her after the first booster shot) and DECREASED APPETITE (Could not eat after the first booster shot) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Nov-2021, Blood glucose: sugar was out of range.    No concomitant drug were reported.   No treatment drug were reported.   This case was linked to MOD-2022-660474 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea
Clinical narrative: Could not get out of bed after the first booster shot; Nausea after the first booster shot, Did not know what day it was after the first booster shot; Sugar was out of range after the first booster shot; Had 5 blankets on her after the first booster shot; Could not eat after the first booster shot; This spontaneous case was reported by a patient and describes the occurrence of BEDRIDDEN (Could not get out of bed after the first booster shot), NAUSEA (Nausea after the first booster shot, Did not know what day it was after the first booster shot), BLOOD GLUCOSE ABNORMAL (Sugar was out of range after the first booster shot), FEELING ABNORMAL (Had  5 blankets on her after the first booster shot) and DECREASED APPETITE (Could not eat after the first booster shot) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031C21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, the patient experienced BEDRIDDEN (Could not get out of bed after the first booster shot), NAUSEA (Nausea after the first booster shot, Did not know what day it was after the first booster shot), BLOOD GLUCOSE ABNORMAL (Sugar was out of range after the first booster shot), FEELING ABNORMAL (Had  5 blankets on her after the first booster shot) and DECREASED APPETITE (Could not eat after the first booster shot). On 07-Nov-2021, BEDRIDDEN (Could not get out of bed after the first booster shot), NAUSEA (Nausea after the first booster shot, Did not know what day it was after the first booster shot), BLOOD GLUCOSE ABNORMAL (Sugar was out of range after the first booster shot), FEELING ABNORMAL (Had  5 blankets on her after the first booster shot) and DECREASED APPETITE (Could not eat after the first booster shot) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Nov-2021, Blood glucose: sugar was out of range.    No concomitant drug were reported.   No treatment drug were reported.   This case was linked to MOD-2022-660474 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache
Clinical narrative: Could not get out of bed after the first booster shot; Nausea after the first booster shot, Did not know what day it was after the first booster shot; Sugar was out of range after the first booster shot; Had 5 blankets on her after the first booster shot; Could not eat after the first booster shot; This spontaneous case was reported by a patient and describes the occurrence of BEDRIDDEN (Could not get out of bed after the first booster shot), NAUSEA (Nausea after the first booster shot, Did not know what day it was after the first booster shot), BLOOD GLUCOSE ABNORMAL (Sugar was out of range after the first booster shot), FEELING ABNORMAL (Had  5 blankets on her after the first booster shot) and DECREASED APPETITE (Could not eat after the first booster shot) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031C21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, the patient experienced BEDRIDDEN (Could not get out of bed after the first booster shot), NAUSEA (Nausea after the first booster shot, Did not know what day it was after the first booster shot), BLOOD GLUCOSE ABNORMAL (Sugar was out of range after the first booster shot), FEELING ABNORMAL (Had  5 blankets on her after the first booster shot) and DECREASED APPETITE (Could not eat after the first booster shot). On 07-Nov-2021, BEDRIDDEN (Could not get out of bed after the first booster shot), NAUSEA (Nausea after the first booster shot, Did not know what day it was after the first booster shot), BLOOD GLUCOSE ABNORMAL (Sugar was out of range after the first booster shot), FEELING ABNORMAL (Had  5 blankets on her after the first booster shot) and DECREASED APPETITE (Could not eat after the first booster shot) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Nov-2021, Blood glucose: sugar was out of range.    No concomitant drug were reported.   No treatment drug were reported.   This case was linked to MOD-2022-660474 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bedridden, Blood glucose, Blood glucose abnormal, Decreased appetite, Feeling abnormal
Clinical narrative: Little headache after primary shots; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (Little headache after primary shots) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031C21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced HEADACHE (Little headache after primary shots). At the time of the report, HEADACHE (Little headache after primary shots) outcome was unknown. No concomitant drug were reported.  No treatment drug were reported. This case was linked to MOD-2022-660468 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea
Clinical narrative: Little headache after primary shots; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (Little headache after primary shots) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031C21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced HEADACHE (Little headache after primary shots). At the time of the report, HEADACHE (Little headache after primary shots) outcome was unknown. No concomitant drug were reported.  No treatment drug were reported. This case was linked to MOD-2022-660468 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache
Clinical narrative: Little headache after primary shots; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (Little headache after primary shots) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031C21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced HEADACHE (Little headache after primary shots). At the time of the report, HEADACHE (Little headache after primary shots) outcome was unknown. No concomitant drug were reported.  No treatment drug were reported. This case was linked to MOD-2022-660468 (Patient Link).
Sex: U
Vaccine: COVID19-2
Symptoms: Migraine
Clinical narrative: Neurologist has seen many other patients who have received the Moderna Covid-19 vaccine and who now have Migraine Headaches. This spontaneous case was reported by a patient and describes the occurrence of MIGRAINE (Neurologist has seen many other patients who have received the Moderna Covid-19 vaccine and who now have Migraine Headaches.) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Neurologist has seen many other patients who have received the Moderna Covid-19 vaccine and who now have Migraine Headaches.). At the time of the report, MIGRAINE (Neurologist has seen many other patients who have received the Moderna Covid-19 vaccine and who now have Migraine Headaches.) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.   This case was linked to MODERNATX, INC.-MOD-2021-187590 (E2B Linked Report), Sender's Comments:  MODERNATX, INC.-MOD-2021-187590: Same reporter (MOD22-026949)
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: Her arm was painful for a week/arm killed me for a week; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Her arm was painful for a week/arm killed me for a week) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     The patient's past medical history included Taste loss (Lost sense of taste) in March 2020, Sore throat (Terrible sore throat) in March 2020 and Feeling abnormal (felt funny electric shocks in her body) in March 2020. Concurrent medical conditions included Perfume sensitivity and Seasonal allergy.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (Her arm was painful for a week/arm killed me for a week). In February 2021, PAIN IN EXTREMITY (Her arm was painful for a week/arm killed me for a week) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant medications were reported.  No other vaccines given within 1 month prior to Moderna COVID-19 vaccine.  No treatment details were reported.   This case was linked to MOD-2022-660536, MOD-2022-660535 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Blindness, Blood pressure measurement, Blood test, Carpal tunnel syndrome
Clinical narrative: Her arm was painful for a week/arm killed me for a week; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Her arm was painful for a week/arm killed me for a week) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     The patient's past medical history included Taste loss (Lost sense of taste) in March 2020, Sore throat (Terrible sore throat) in March 2020 and Feeling abnormal (felt funny electric shocks in her body) in March 2020. Concurrent medical conditions included Perfume sensitivity and Seasonal allergy.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (Her arm was painful for a week/arm killed me for a week). In February 2021, PAIN IN EXTREMITY (Her arm was painful for a week/arm killed me for a week) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant medications were reported.  No other vaccines given within 1 month prior to Moderna COVID-19 vaccine.  No treatment details were reported.   This case was linked to MOD-2022-660536, MOD-2022-660535 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Hypertension, Hypoaesthesia, Neck pain, Night sweats
Clinical narrative: Her arm was painful for a week/arm killed me for a week; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Her arm was painful for a week/arm killed me for a week) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     The patient's past medical history included Taste loss (Lost sense of taste) in March 2020, Sore throat (Terrible sore throat) in March 2020 and Feeling abnormal (felt funny electric shocks in her body) in March 2020. Concurrent medical conditions included Perfume sensitivity and Seasonal allergy.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (Her arm was painful for a week/arm killed me for a week). In February 2021, PAIN IN EXTREMITY (Her arm was painful for a week/arm killed me for a week) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant medications were reported.  No other vaccines given within 1 month prior to Moderna COVID-19 vaccine.  No treatment details were reported.   This case was linked to MOD-2022-660536, MOD-2022-660535 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Papilloedema, Paraesthesia, Peripheral swelling, Rash, Urinary tract infection
Clinical narrative: Her arm was painful for a week/arm killed me for a week; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Her arm was painful for a week/arm killed me for a week) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     The patient's past medical history included Taste loss (Lost sense of taste) in March 2020, Sore throat (Terrible sore throat) in March 2020 and Feeling abnormal (felt funny electric shocks in her body) in March 2020. Concurrent medical conditions included Perfume sensitivity and Seasonal allergy.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (Her arm was painful for a week/arm killed me for a week). In February 2021, PAIN IN EXTREMITY (Her arm was painful for a week/arm killed me for a week) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant medications were reported.  No other vaccines given within 1 month prior to Moderna COVID-19 vaccine.  No treatment details were reported.   This case was linked to MOD-2022-660536, MOD-2022-660535 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vision blurred
Clinical narrative: Her arm was painful for a week/arm killed me for a week; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Her arm was painful for a week/arm killed me for a week) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     The patient's past medical history included Taste loss (Lost sense of taste) in March 2020, Sore throat (Terrible sore throat) in March 2020 and Feeling abnormal (felt funny electric shocks in her body) in March 2020. Concurrent medical conditions included Perfume sensitivity and Seasonal allergy.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (Her arm was painful for a week/arm killed me for a week). In February 2021, PAIN IN EXTREMITY (Her arm was painful for a week/arm killed me for a week) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant medications were reported.  No other vaccines given within 1 month prior to Moderna COVID-19 vaccine.  No treatment details were reported.   This case was linked to MOD-2022-660536, MOD-2022-660535 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bedridden, Feeling abnormal, Mobility decreased
Clinical narrative: Her arm was painful for a week/arm killed me for a week; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Her arm was painful for a week/arm killed me for a week) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     The patient's past medical history included Taste loss (Lost sense of taste) in March 2020, Sore throat (Terrible sore throat) in March 2020 and Feeling abnormal (felt funny electric shocks in her body) in March 2020. Concurrent medical conditions included Perfume sensitivity and Seasonal allergy.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (Her arm was painful for a week/arm killed me for a week). In February 2021, PAIN IN EXTREMITY (Her arm was painful for a week/arm killed me for a week) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant medications were reported.  No other vaccines given within 1 month prior to Moderna COVID-19 vaccine.  No treatment details were reported.   This case was linked to MOD-2022-660536, MOD-2022-660535 (Patient Link).